市場調査レポート

商品コード

1302260

循環腫瘍細胞市場：検体別、技術別、製品別、用途別-2023-2030年の世界予測

Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 739,704円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 895,464円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,051,224円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,362,744円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の循環腫瘍細胞市場は、2023年に124億4,000万米ドル、CAGR13.97%で大幅な成長が予測され、2030年には311億2,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の循環腫瘍細胞市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.循環腫瘍細胞の世界市場規模および予測は？

2.予測期間中、世界の循環腫瘍細胞市場を形成するCOVID-19の阻害要因と影響は？

3.循環腫瘍細胞の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.循環腫瘍細胞の世界市場における競争戦略は？

5.循環腫瘍細胞の世界市場における技術動向と規制の枠組みは？

6.循環腫瘍細胞の世界市場における主要ベンダーの市場シェアは？

7.循環腫瘍細胞の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - がん関連治療への支出の増加
  - 世界中でのがんの蔓延
  - がんの早期発見に対する意識の向上と注目
- 抑制要因
  - CTCシステムに関する認識の欠如
- 機会
  - 生物工学および生物医学実践における技術の進歩
  - 近年の低侵襲診断の需要
- 課題
  - CTCテクノロジーの承認に対する政府の厳しい規制
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章循環腫瘍細胞市場標本別

血
骨髄

第7章循環腫瘍細胞市場：技術別

CTC分析
CTCの検出および濃縮方法
- 組み合わせた方法
- 密度に基づく分離
- 免疫捕捉
  - ネガティブセレクション
  - ポジティブセレクション
- サイズに基づく分離
  - 膜ベース
  - マイクロ流体ベース
CTC直接検出法
- 顕微鏡検査
- SERS

第8章循環腫瘍細胞市場：製品別

採血管
デバイスまたはシステム
キットと試薬

第9章循環腫瘍細胞市場：用途別

臨床/リキッドバイオプシー
- リスクアセスメント
- スクリーニングとモニタリング
調査
- がん幹細胞と腫瘍形成の調査
- 薬剤または治療法の開発

第10章南北アメリカの循環腫瘍細胞市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋地域の循環腫瘍細胞市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカの循環腫瘍細胞市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第14章掲載企業一覧

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
FIGURE 2. CIRCULATING TUMOR CELL MARKET SIZE, 2022 VS 2030
FIGURE 3. CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2022 VS 2030 (%)
FIGURE 5. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 6. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 7. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 8. CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. CIRCULATING TUMOR CELL MARKET DYNAMICS
FIGURE 10. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 5. CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 10. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 14. CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 18. CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 22. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CIRCULATING TUMOR CELL MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CIRCULATING TUMOR CELL MARKET SIZE, BY SERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 31. CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 35. CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG OR THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 69. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 70. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 72. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 78. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 121. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 122. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 124. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 125. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 126. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 127. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 130. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 131. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 132. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 134. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 135. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 136. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 137. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 140. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 151. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 152. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 154. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 155. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 211. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 212. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 215. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 216. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 217. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 220. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 242. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 243. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 252. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 253. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 257. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 258. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 262. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 271. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 272. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 273. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 275. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 276. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 277. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 278. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 281. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 282. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 283. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 285. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 286. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 287. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 288. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 291. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 302. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 303. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 305. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 306. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 307. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 308. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 311. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 322. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 323. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 325. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY I

Product Code: MRR-A339DAEF9FAB

The Global Circulating Tumor Cell Market is forecasted to grow significantly, with a projected USD 12.44 billion in 2023 at a CAGR of 13.97% and expected to reach a staggering USD 31.12 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Circulating Tumor Cell Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Circulating Tumor Cell Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Specimen, market is studied across Blood and Bone Marrow. The Blood is projected to witness significant market share during forecast period.

Based on Technology, market is studied across CTC Analysis, CTC Detection & Enrichment Methods, and CTC Direct Detection Methods. The CTC Detection & Enrichment Methods is further studied across Combined Methods, Density-Based Separation, Immunocapture, and Size-Based Separation. The Immunocapture is further studied across Negative Selection and Positive Selection. The Size-Based Separation is further studied across Membrane-Based and Microfluidic-Based. The CTC Direct Detection Methods is further studied across Microscopy and SERS. The CTC Direct Detection Methods is projected to witness significant market share during forecast period.

Based on Product, market is studied across Blood Collection Tubes, Devices or Systems, and Kits & Reagents. The Blood Collection Tubes is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical/ Liquid Biopsy and Research. The Clinical/ Liquid Biopsy is further studied across Risk Assessment and Screening & Monitoring. The Research is further studied across Cancer Stem Cell & Tumorigenesis Research and Drug or Therapy Development. The Research is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Circulating Tumor Cell Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Circulating Tumor Cell Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Circulating Tumor Cell Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Circulating Tumor Cell Market?

4. What is the competitive strategic window for opportunities in the Global Circulating Tumor Cell Market?

5. What are the technology trends and regulatory frameworks in the Global Circulating Tumor Cell Market?

6. What is the market share of the leading vendors in the Global Circulating Tumor Cell Market?

7. What modes and strategic moves are considered suitable for entering the Global Circulating Tumor Cell Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Circulating Tumor Cell Market, by Specimen, 2022 vs 2030
4.3. Circulating Tumor Cell Market, by Technology, 2022 vs 2030
4.4. Circulating Tumor Cell Market, by Product, 2022 vs 2030
4.5. Circulating Tumor Cell Market, by Application, 2022 vs 2030
4.6. Circulating Tumor Cell Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increased spending in cancer-related therapies
  - 5.1.1.2. Prevalence of cancer across the globe
  - 5.1.1.3. Rising awareness and focus on early cancer detection
- 5.1.2. Restraints
  - 5.1.2.1. Lack of awareness about CTC systems
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in bioengineering and biomedical practices
  - 5.1.3.2. Demand for minimally invasive diagnostics in recent years
- 5.1.4. Challenges
  - 5.1.4.1. Stringent government regulations for the approval of CTC technologies
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Circulating Tumor Cell Market, by Specimen

6.1. Introduction
6.2. Blood
6.3. Bone Marrow

7. Circulating Tumor Cell Market, by Technology

7.1. Introduction
7.2. CTC Analysis
7.3. CTC Detection & Enrichment Methods
- 7.3.1. Combined Methods
- 7.3.2. Density-Based Separation
- 7.3.3. Immunocapture
  - 7.3.3.1. Negative Selection
  - 7.3.3.2. Positive Selection
- 7.3.4. Size-Based Separation
  - 7.3.4.1. Membrane-Based
  - 7.3.4.2. Microfluidic-Based
7.4. CTC Direct Detection Methods
- 7.4.1. Microscopy
- 7.4.2. SERS

8. Circulating Tumor Cell Market, by Product

8.1. Introduction
8.2. Blood Collection Tubes
8.3. Devices or Systems
8.4. Kits & Reagents

9. Circulating Tumor Cell Market, by Application

9.1. Introduction
9.2. Clinical/ Liquid Biopsy
- 9.2.1. Risk Assessment
- 9.2.2. Screening & Monitoring
9.3. Research
- 9.3.1. Cancer Stem Cell & Tumorigenesis Research
- 9.3.2. Drug or Therapy Development

10. Americas Circulating Tumor Cell Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Circulating Tumor Cell Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Circulating Tumor Cell Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

循環腫瘍細胞市場：検体別、技術別、製品別、用途別-2023-2030年の世界予測

Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 循環腫瘍細胞市場標本別

第7章 循環腫瘍細胞市場：技術別

第8章 循環腫瘍細胞市場：製品別

第9章 循環腫瘍細胞市場：用途別

第10章 南北アメリカの循環腫瘍細胞市場

第11章 アジア太平洋地域の循環腫瘍細胞市場

第12章 欧州・中東・アフリカの循環腫瘍細胞市場

第13章 競合情勢

第14章 掲載企業一覧

第15章 付録